WallStreetZenWallStreetZen

NASDAQ: IRWD
Ironwood Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ironwood Pharmaceuticals earnings were $880.0k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IRWD earnings report on Dec 31, 2024 announced Q4 2024 earnings of $2.3M, down 38.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IRWD reported annual earnings of $880.0k, with -100.1% growth. The next IRWD earnings date is May 7, 2025.

IRWD past earnings growth

How has IRWD's earnings growth performed historically?

Company
N/A
Industry
55.51%
Market
63.03%
IRWD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IRWD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

IRWD earnings history

Current Revenue
$351.4M
Current Earnings
$880.0k
Current Profit Margin
0.3%

IRWD Return on Equity

Current Company
-0.3%
Current Industry
12.5%
Current Market
34.1%
IRWD's Return on Equity (-0.3%)... subscribe to Premium to read more.
High Return on Equity Performance

IRWD undefined

Current Company
0.2%
Current Industry
5.5%
IRWD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IRWD announces earnings.

IRWD undefined

Current Company
31.48%
Current Industry
12%
IRWD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IRWD vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IRWD$100.24M$880.00k-41.01%$0.01
OGI-$27.75M-$36.52MN/A-$0.39
BIOA-$68.57M-$71.11MN/A-$6.63
OPTN-$1.20M-$21.54MN/A-$2.12
DERM-$8.40M-$14.67MN/A-$0.72
View Top Pharmaceutical Stocks

IRWD earnings dates

Next earnings date
May 7, 2025

Ironwood Pharmaceuticals Earnings Reports & History FAQ

What were Ironwood Pharmaceuticals's earnings last quarter?

On IRWD's earnings call on Invalid Date, Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q4 2024 earnings per share (EPS) of $0.02, up Infinity% year over year. Total IRWD earnings for the quarter were $2.26 million. In the same quarter last year, Ironwood Pharmaceuticals's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Ironwood Pharmaceuticals stock.

When does Ironwood Pharmaceuticals report earnings?

The next IRWD earnings date is Invalid Date. Add IRWD to your watchlist to be reminded of Ironwood Pharmaceuticals's next earnings date.

Is Ironwood Pharmaceuticals profitable or losing money?

As of the last Ironwood Pharmaceuticals earnings report, Ironwood Pharmaceuticals is currently profitable. Ironwood Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $880.00 thousand, a 100.09% decrease year over year.

What was IRWD's earnings growth in the past year?

As of Ironwood Pharmaceuticals's earnings date in Invalid Date, Ironwood Pharmaceuticals's earnings has grown year over year. IRWD earnings in the past year totalled $880.00 thousand.

What are Ironwood Pharmaceuticals's earnings expectations?

The current EPS estimate for Ironwood Pharmaceuticals's earnings report in Invalid Date is $0.20.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.